1. Home
  2. TNXP vs CWBC Comparison

TNXP vs CWBC Comparison

Compare TNXP & CWBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • CWBC
  • Stock Information
  • Founded
  • TNXP 2007
  • CWBC 1989
  • Country
  • TNXP United States
  • CWBC United States
  • Employees
  • TNXP N/A
  • CWBC N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • CWBC Major Banks
  • Sector
  • TNXP Health Care
  • CWBC Finance
  • Exchange
  • TNXP Nasdaq
  • CWBC Nasdaq
  • Market Cap
  • TNXP 335.6M
  • CWBC 398.6M
  • IPO Year
  • TNXP N/A
  • CWBC 1996
  • Fundamental
  • Price
  • TNXP $26.54
  • CWBC $21.23
  • Analyst Decision
  • TNXP Buy
  • CWBC Buy
  • Analyst Count
  • TNXP 1
  • CWBC 3
  • Target Price
  • TNXP $70.00
  • CWBC $21.67
  • AVG Volume (30 Days)
  • TNXP 1.9M
  • CWBC 41.5K
  • Earning Date
  • TNXP 08-11-2025
  • CWBC 10-23-2025
  • Dividend Yield
  • TNXP N/A
  • CWBC 2.26%
  • EPS Growth
  • TNXP N/A
  • CWBC 95.72
  • EPS
  • TNXP N/A
  • CWBC 1.39
  • Revenue
  • TNXP $9,831,000.00
  • CWBC $132,829,000.00
  • Revenue This Year
  • TNXP $21.19
  • CWBC $30.64
  • Revenue Next Year
  • TNXP $722.94
  • CWBC $6.58
  • P/E Ratio
  • TNXP N/A
  • CWBC $15.22
  • Revenue Growth
  • TNXP N/A
  • CWBC 55.84
  • 52 Week Low
  • TNXP $6.76
  • CWBC $15.57
  • 52 Week High
  • TNXP $130.00
  • CWBC $22.89
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 32.47
  • CWBC 62.00
  • Support Level
  • TNXP $34.50
  • CWBC $20.90
  • Resistance Level
  • TNXP $29.70
  • CWBC $21.50
  • Average True Range (ATR)
  • TNXP 3.35
  • CWBC 0.40
  • MACD
  • TNXP -1.55
  • CWBC 0.05
  • Stochastic Oscillator
  • TNXP 4.29
  • CWBC 78.30

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About CWBC Community West Bancshares

Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.

Share on Social Networks: